Back
56
Day Range
$0.19
$0.19
52-Week Range
$0.05
$0.21
Volume
300
50D / 200D Avg
$0.18
/
$0.12
Prev Close
$0.19
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -7.9 | 0.3 |
| P/B | 0.4 | 3.0 |
| ROE % | -4.9 | 3.7 |
| Net Margin % | -11.4 | 3.8 |
| Rev Growth 5Y % | -6.3 | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$0.11
$0.11 – $0.11
|
4.42B | 1 |
| FY2026 |
$0.08
$0.08 – $0.08
|
3.36B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-08-29 | N/A | $0.00 | — |
| 2025-03-26 | N/A | $0.00 | — |
| 2024-08-30 | N/A | $0.00 | — |
| 2024-03-28 | N/A | $0.00 | — |
| 2023-06-30 | N/A | $0.00 | — |
| 2022-12-31 | N/A | -$0.03 | — |
| 2022-06-30 | N/A | $0.00 | — |
| 2021-12-31 | N/A | $0.00 | — |
Dividend History
Yield
0.05%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Sep 30, 2025 | Oct 10, 2025 | $0.00 | 1.40% |
| Oct 02, 2024 | Oct 10, 2024 | $0.00 | 4.15% |
| Jun 06, 2023 | Jun 23, 2023 | $0.00 | 9.48% |
| Oct 04, 2022 | Oct 13, 2022 | $0.00 | 17.05% |
| May 26, 2022 | Jun 14, 2022 | $0.02 | 13.03% |
| Jul 05, 2021 | Jul 15, 2021 | $0.00 | 3.27% |
| Sep 29, 2020 | Oct 14, 2020 | $0.00 | 23.61% |
| Jun 18, 2020 | Jul 03, 2020 | $0.02 | 42.55% |
| Oct 17, 2019 | Oct 30, 2019 | $0.00 | 3.29% |
| Jun 05, 2019 | Jun 19, 2019 | $0.00 | 1.09% |
| Oct 18, 2018 | Oct 31, 2018 | $0.00 | 1.41% |
| Jun 07, 2018 | Jun 20, 2018 | $0.00 | 1.82% |
| Sep 01, 2017 | Sep 13, 2017 | $0.00 | 3.78% |
| Jun 22, 2017 | Jul 05, 2017 | $0.01 | 3.56% |
| Sep 06, 2016 | Sep 15, 2016 | $0.00 | 5.00% |
| Jun 30, 2016 | Jul 13, 2016 | $0.01 | 4.45% |
| Dec 17, 2015 | Dec 30, 2015 | $0.00 | 0.77% |
| Sep 11, 2015 | Sep 23, 2015 | $0.00 | 0.39% |
| Sep 10, 2014 | Sep 24, 2014 | $0.00 | 0.58% |
| Jun 05, 2014 | Jun 20, 2014 | $0.00 | 7.03% |
Key Takeaways
Revenue declined -6.28% annually over 5 years
Debt/Equity of 0.22 — conservative balance sheet
Generating 57.51M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8.46%
Capital efficient — spends only 9.80% of revenue on capex
Growth
Revenue Growth (5Y)
-6.28%
Revenue (1Y)2.18%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-4.92%
ROIC-1.94%
Net Margin-11.40%
Op. Margin-7.27%
Safety
Debt / Equity
0.22
Current Ratio1.73
Interest Coverage-0.50
Valuation
P/E Ratio
-7.87
Forward P/EN/A
P/B Ratio0.39
EV/EBITDAN/A
Dividend Yield0.05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.18% | Revenue Growth (3Y) | -6.64% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -6.28% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.90B | Net Income (TTM) | -216.66M |
| ROE | -4.92% | ROA | -2.06% |
| Gross Margin | 65.32% | Operating Margin | -7.27% |
| Net Margin | -11.40% | Free Cash Flow (TTM) | 57.51M |
| ROIC | -1.94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.22 | Current Ratio | 1.73 |
| Interest Coverage | -0.50 | ||
| Dividends | |||
| Dividend Yield | 0.05% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -7.87 | Forward P/E | N/A |
| P/B Ratio | 0.39 | P/S Ratio | 0.90 |
| PEG Ratio | -0.05 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 3.37% | ||
| Market Cap | 1.71B | Enterprise Value | -942.07M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1.90B | 1.86B | 2.18B | 3.04B | 2.46B |
| Net Income | -216.66M | -54.02M | -1.91B | 416.51M | 473.38M |
| EPS (Diluted) | -0.02 | -0.01 | -0.21 | 0.04 | 0.05 |
| Gross Profit | 1.24B | 1.30B | 1.49B | 2.43B | 1.91B |
| Operating Income | -138.13M | 161.70M | -1.83B | 771.95M | 787.13M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 10.53B | 11.54B | 12.14B | 14.50B | 13.04B |
| Total Liabilities | 5.58B | 6.40B | 6.50B | 5.35B | 3.10B |
| Shareholders' Equity | 4.37B | 4.43B | 4.74B | 8.28B | 9.19B |
| Total Debt | 974.01M | 1.26B | 1.29B | 1.08B | 755.05M |
| Cash & Equivalents | 3.62B | 3.89B | 3.83B | 5.68B | 4.60B |
| Current Assets | 5.72B | 6.20B | 6.55B | 7.74B | 6.40B |
| Current Liabilities | 3.31B | 4.11B | 2.53B | 2.50B | 2.44B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#205 of 827
Recent Activity
Entered
Deep Value Investing (Seth Klarman)
Mar 24, 2026